ARTICLE | Distillery Therapeutics
Therapeutics: NLR family pyrin domain containing 3 (NLRP3; NALP3; CIAS1)
April 9, 2015 7:00 AM UTC
In vitro and mouse studies suggest enhancing levels of β-hydroxybutyrate could help treat CAPS and other NLRP3 inflammasome-driven diseases. In an assay of NLRP3 activity in mouse and human macrophage...